Materials, components, assembly, design services, and devices including inhalers, nebulizers, and spray pumps
Presspart specialises in the manufacturer of bespoke, concept-to-completion, metal and plastic drug delivery components and devices for the pharmaceutical market. Presspart has over 40 years’ experience in supplying metal metered dose inhaler (MDI) canisters and valve components, plastic actuators and new drug delivery devices. In fact three quarters of inhalers in the world will contain a component manufactured by Presspart, with millions of patients putting their trust in these components every day.
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries. Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.
Nemera’s services and products cover several key delivery routes:
• Ear, Nose, Throat (sprays/ pumps, etc.),
• Inhalation (pMDI, DPIs),
• Ophthalmic (preservative-free multidose eye droppers),
• Dermal and Transdermal (airless & atmospheric dispensers),
• Parenteral (auto-injectors, pens, safety devices & implanters).
Innovating for patients is at the core of Nemera’s mission. More than 100 engineers and experts work to achieve this at the Innovation Centre at La Verpillière, near Lyon, France.
As inventors of the very first metered dose inhaler (MDI), and being behind the latest MDIs, 3M has been at the forefront of inhalation technology for over 50 years. Our experience spans the entire system, from feasibility to selecting the right components – through to commercial scale production. Whether you’re looking for a primary contract fill manufacturer, a second source of supply, for cold or pressure fill, our trusted cGMP manufacturing capabilities provide you with reassurance that your product will be available for market. We take the risk out of commercializing your new product, from start to finish.
Coalesce is developing a portfolio of inhalation devices which are available for licensing. All of our devices utilise our innovative dose counter technology, and can be configured for NCE, LCM, and Generic applications. We have deep knowledge of inhalers, garnered from years of developing inhalation products and analysing existing devices. The platforms we have chosen to develop have an established market need. Our scientific approach to development ensures that the needs of all stakeholders are demonstrably met, resulting in simple-to-use, reliable, low-cost inhalers for global regulated markets.”
Merxin designs and supplies inhaler devices for lung and nasal delivery. Our MRX001 blister DPI (generic for Diskus) and our MRX003 capsule DPI (generic for HandiHaler) have both achieved in vitro BE based on NGI data, API dissolution and airflow resistance. We recently launched MRX004 soft mist inhaler (generic for Respimat) and are developing a generic Ellipta device. Merxin is active in the field of cannabinoids therapies and is developing CBD and THC finished dosage forms with Perlen AG. We are fielding requests — contact us before someone else snaps up these products. Twitter: @MRXdevices #Reduce Cost, #Reduce Risk, #Increase Success
Visit the Merxin website
Team Consulting are recognised globally as experts in the design and development of medical devices. That’s all we do and we are proud of this focus. It enables us to deliver real insight and expertise to our clients. Everybody at Team is driven by the same desire, to make things better by working in collaboration with clients and each other. Whether ‘things’ means people or the products we work on, we apply the same commitment to do the best and be the best that we can. This focus and desire is a powerful combination and one that highlights why our clients trust us over and over again.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.